Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Haleon Plc on November 3, 2025, for the month of November 2025. Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The filing specifically addresses the company's total voting rights and capital structure as of October 31, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a capital disclosure rather than a financial performance statement.
Material Changes and Capital Structure
As of October 31, 2025, the company reported the following capital figures:
- Total Ordinary Shares Issued: 8,952,353,648 shares of £0.01 each.
- Treasury Shares: 45,930,962 shares held by the company.
- Shares with Voting Rights: 8,906,422,686 shares.
The number of shares with voting rights serves as the denominator for shareholders to calculate notification obligations under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on performance, specific risks, contingencies, or unusual items. The document focuses solely on share capital data.
Key Facts for Investor Verification
- Verify the denominator for disclosure calculations is 8,906,422,686 voting shares.
- Confirm the total issued share count of 8,952,353,648 as of October 31, 2025.
- Note that 45,930,962 shares are held in treasury and do not carry voting rights.
- Contact the Company Secretary at company.secretary@haleon.com for notifiable interest submissions.